Gulpharm Ltd 15453334 false 2024-01-30 2025-01-31 2025-01-31 The principal activity of the company is Agent for the sale of pharmaceuticals Digita Accounts Production Advanced 6.30.9574.0 true 15453334 2024-01-30 2025-01-31 15453334 2025-01-31 15453334 bus:Director1 1 2025-01-31 15453334 core:CurrentFinancialInstruments core:WithinOneYear 2025-01-31 15453334 bus:Micro-entities 2024-01-30 2025-01-31 15453334 bus:AuditExemptWithAccountantsReport 2024-01-30 2025-01-31 15453334 bus:FilletedAccounts 2024-01-30 2025-01-31 15453334 bus:SmallCompaniesRegimeForAccounts 2024-01-30 2025-01-31 15453334 bus:RegisteredOffice 2024-01-30 2025-01-31 15453334 bus:Director1 2024-01-30 2025-01-31 15453334 bus:Director1 1 2024-01-30 2025-01-31 15453334 bus:PrivateLimitedCompanyLtd 2024-01-30 2025-01-31 15453334 bus:Agent1 2024-01-30 2025-01-31 15453334 countries:EnglandWales 2024-01-30 2025-01-31 15453334 bus:Director1 1 2024-01-29 iso4217:GBP xbrli:pure

Registration number: 15453334

Gulpharm Ltd

Unaudited Financial Statements

30 January 2024 to 31 January 2025

image-name

 

Gulpharm Ltd

Contents

Accountants' Report

1

Balance Sheet

2

 

Chartered Accountants' Report to the Director on the Preparation of the Unaudited Statutory Accounts of
Gulpharm Ltd
for the Period Ended 31 January 2025

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Gulpharm Ltd for the period ended 31 January 2025 as set out on pages 2 to 4 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com/regulation.

This report is made solely to the Board of Directors of Gulpharm Ltd, as a body, in accordance with the terms of our engagement letter dated 19 March 2024. Our work has been undertaken solely to prepare for your approval the accounts of Gulpharm Ltd and state those matters that we have agreed to state to the Board of Directors of Gulpharm Ltd, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Gulpharm Ltd and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Gulpharm Ltd has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Gulpharm Ltd. You consider that Gulpharm Ltd is exempt from the statutory audit requirement for the period.

We have not been instructed to carry out an audit or a review of the accounts of Gulpharm Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.



Dodd & Co Limited
Chartered Accountants
FIFTEEN Rosehill
Montgomery Way
Rosehill Estate
CARLISLE
CA1 2RW

1 April 2025

 

Gulpharm Ltd

(Registration number: 15453334)
Balance Sheet as at 31 January 2025

31 January 2025
£

Current assets

 

73,932

Creditors: Amounts falling due within one year

 

(18,701)

Total assets less current liabilities

 

55,231

Accruals and deferred income

 

(1,250)

   

53,981

Capital and reserves

 

53,981

 

Gulpharm Ltd

(Registration number: 15453334)
Balance Sheet as at 31 January 2025 (continued)

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
25 Moor Side
Boston Spa
Wetherby
LS23 6PD
England

2

Staff numbers

The average number of persons employed by the company (including the director) during the period, was 1.

3

Related party transactions

Transactions with the director

2025

At 30 January 2024
£

Advances
£

Repayments
£

Dividends credited
£

Interest
£

At 31 January 2025
£

C I Gulliford

Loan to director

-

16,515

(2,795)

-

110

13,830

             
         

 

Directors' advances are repayable on demand.

Interest has been charged at a rate of 2.25% on advances to directors.

 

Gulpharm Ltd

(Registration number: 15453334)
Balance Sheet as at 31 January 2025 (continued)

For the financial period ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 1 April 2025
 

.........................................
C I Gulliford
Director